AT282821B - Verfahren zur Herstellung einer antigenfreien Vaccine - Google Patents
Verfahren zur Herstellung einer antigenfreien VaccineInfo
- Publication number
- AT282821B AT282821B AT576668A AT576668A AT282821B AT 282821 B AT282821 B AT 282821B AT 576668 A AT576668 A AT 576668A AT 576668 A AT576668 A AT 576668A AT 282821 B AT282821 B AT 282821B
- Authority
- AT
- Austria
- Prior art keywords
- antigen
- production
- free vaccine
- vaccine
- free
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEJ0033936 | 1967-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AT282821B true AT282821B (de) | 1970-07-10 |
Family
ID=7204943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT576668A AT282821B (de) | 1967-06-19 | 1968-06-17 | Verfahren zur Herstellung einer antigenfreien Vaccine |
Country Status (13)
Country | Link |
---|---|
AT (1) | AT282821B (da) |
BE (1) | BE716806A (da) |
BR (1) | BR6899970D0 (da) |
CH (1) | CH513241A (da) |
DE (1) | DE1617545C2 (da) |
DK (1) | DK119724B (da) |
ES (1) | ES355121A1 (da) |
FR (2) | FR1588820A (da) |
GB (1) | GB1229888A (da) |
IE (1) | IE32140B1 (da) |
IL (1) | IL30168A (da) |
NL (1) | NL6808486A (da) |
NO (1) | NO124840B (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE754934A (fr) * | 1969-08-16 | 1971-02-17 | Jachertz Diether | Procede de production enzymatique d'arn-messager |
GB1594097A (en) | 1976-12-16 | 1981-07-30 | Int Inst Of Differentiation | Production of specific immune nucleic acids cell dialysates and antibodies |
DE3115559A1 (de) * | 1981-04-16 | 1982-10-28 | Kommanditgesellschaft Schwarzhaupt, 5000 Köln | Hochgereinigte informatorische ribonukleinsaeure (i-rns), verfahren zur herstellung und verwendung derselben |
GB2216416B (en) * | 1988-03-11 | 1992-06-24 | Sandoz Ltd | Nucleobase source for the stimulation of the immune system |
US6867195B1 (en) | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US6214804B1 (en) | 1989-03-21 | 2001-04-10 | Vical Incorporated | Induction of a protective immune response in a mammal by injecting a DNA sequence |
US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
-
1967
- 1967-06-19 DE DE1617545A patent/DE1617545C2/de not_active Expired
-
1968
- 1968-06-12 IL IL30168A patent/IL30168A/en unknown
- 1968-06-15 NO NO2340/68A patent/NO124840B/no unknown
- 1968-06-17 CH CH893668A patent/CH513241A/de not_active IP Right Cessation
- 1968-06-17 AT AT576668A patent/AT282821B/de not_active IP Right Cessation
- 1968-06-17 NL NL6808486A patent/NL6808486A/xx unknown
- 1968-06-17 IE IE713/68A patent/IE32140B1/xx unknown
- 1968-06-18 DK DK286268AA patent/DK119724B/da unknown
- 1968-06-18 ES ES355121A patent/ES355121A1/es not_active Expired
- 1968-06-19 BE BE716806D patent/BE716806A/xx unknown
- 1968-06-19 FR FR1588820D patent/FR1588820A/fr not_active Expired
- 1968-06-19 BR BR199970/68A patent/BR6899970D0/pt unknown
- 1968-06-19 GB GB1229888D patent/GB1229888A/en not_active Expired
- 1968-09-18 FR FR166589A patent/FR7781M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IL30168A0 (en) | 1968-08-22 |
NO124840B (da) | 1972-06-12 |
FR7781M (da) | 1970-03-23 |
FR1588820A (da) | 1970-03-16 |
DK119724B (da) | 1971-02-15 |
GB1229888A (da) | 1971-04-28 |
IE32140B1 (en) | 1973-04-18 |
IE32140L (en) | 1968-12-19 |
ES355121A1 (es) | 1969-11-16 |
BE716806A (da) | 1968-12-19 |
DE1617545C2 (de) | 1983-11-03 |
DE1617545A1 (de) | 1971-04-01 |
BR6899970D0 (pt) | 1973-02-13 |
IL30168A (en) | 1973-05-31 |
NL6808486A (da) | 1968-12-20 |
CH513241A (de) | 1971-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT281778B (de) | Verfahren zur Herstellung von Alk-3-en-1-olen | |
AT283594B (de) | Verfahren zur Herstellung von 7-Halogen-octopyranosiden | |
AT279602B (de) | Verfahren zur Herstellung von Pyrrol-3-yl-ketonen | |
CH504421A (de) | Verfahren zur Herstellung von Bis-thioureido-benzolen | |
AT282822B (de) | Verfahren zur Herstellung adsorbierter Vakzinen | |
CH499541A (de) | Verfahren zur Herstellung von Pyridyl-benzopyranen | |
CH502292A (de) | Verfahren zur Herstellung von o-Isopropylaminobenzophenonen | |
AT282821B (de) | Verfahren zur Herstellung einer antigenfreien Vaccine | |
CH507206A (de) | Verfahren zur Herstellung substituierter 4-Aryl-3-hydroxybutyramide | |
CH545294A (de) | Verfahren zur Herstellung von substituierten Benzimidazolen | |
AT283357B (de) | Verfahren zur Herstellung von 2-Aryl-v-triazolen | |
CH502993A (de) | Verfahren zur Herstellung von Ketonitrilen | |
CH483425A (de) | Verfahren zur Herstellung von p-Alkoxy-piperidin-amiden | |
AT278001B (de) | Verfahren zur Herstellung von N-Trityl-imidazolen | |
CH484930A (de) | Verfahren zur Herstellung von Aryloxazolen | |
AT281420B (de) | Verfahren zur Herstellung von α-Triorganosiloxy-ω-hydroxy-diorganopolysiloxanen | |
CH497438A (de) | Verfahren zur Herstellung von Difluor-s-triazinen | |
AT280309B (de) | Verfahren zur Herstellung von 3-Methansulfonylphenthiazinen | |
CH498114A (de) | Verfahren zur Herstellung von 2-N-substituierten 2-Amino-5-nitropyridinen | |
AT284140B (de) | Verfahren zur Herstellung von Pyrazinamidoguanidinen | |
CH505784A (de) | Verfahren zur Herstellung von 1-Brom-4-acylaminoanthrachinonen | |
CH504394A (de) | Verfahren zur Herstellung von 6-Alkyl-citronellolen | |
CH496000A (de) | Verfahren zur Herstellung von Benzimidazol-N-Oxyden | |
CH499492A (de) | Verfahren zur Herstellung von äthinylsubstituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen | |
AT273369B (de) | Verfahren zur Herstellung einer Röteln-Vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |